3,4-Dihydroxy-6-[18F]-Fluoro-L-Phenylalanine Positron Emission Tomography in Patients With Central Motor Disorders and in Evaluation of Brain and Other Tumors-Reference-Cited by-同舟云学术

3,4-Dihydroxy-6-[18F]-Fluoro-L-Phenylalanine Positron Emission Tomography in Patients With Central Motor Disorders and in Evaluation of Brain and Other Tumors

Published:2007-11 Issue:6 Volume:37 Page:440-450
ISSN:0001-2998
Container-title:Seminars in Nuclear Medicine
language:en
Short-container-title:Seminars in Nuclear Medicine

Author:

Seibyl John P.,Chen Wei,Silverman Daniel H.S.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference96 articles.

1. Striatal dopamine metabolism in living monkeys examined by positron emission tomography;Garnett;Brain Res,1983

2. Dopamine visualized in the basal ganglia of living man;Garnett;Nature,1983

3. Positron emission tomography in clinical neurology;Herholz;Mol Imaging Biol,2004

4. Early recognition of Parkinson’s disease;Yahr;Hosp Pract (Off Ed),1981

5. Description of Parkinson’s disease as a clinical syndrome;Fahn;Ann N Y Acad Sci,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Imaging in Oncology;Molecular Imaging and Targeted Therapy;2023

2. Automatic Production of [18F]F-DOPA Using the Raytest SynChrom R&D Module;Pharmaceuticals;2022-12-22

3. Radiopharmaceuticals in Pediatric Nuclear Medicine;Handbook of Radiopharmaceuticals;2020-12-21

4. Nucleophilic Synthesis of 6-l-[18F]FDOPA. Is Copper-Mediated Radiofluorination the Answer?;Molecules;2020-09-23

5. An Overview of PET Radiopharmaceuticals in Clinical Use: Regulatory, Quality and Pharmacopeia Monographs of the United States and Europe;Nuclear Medicine Physics;2019-07-24